Prestige Consumer Healthcare Inc. (PBH)

↓ Download CSV

CIK 0001295947 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Mar 31

In fiscal 2026, Prestige Consumer Healthcare Inc. reported revenue of $1.09B, down 4.3% from the prior year. The company was profitable, with a net margin of 17.5% and a gross margin of 54.7%. It held $3.49B in total assets against $1.61B in total liabilities.

Key ratios (FY2026)

54.7%
Gross margin
28.4%
Operating margin
17.5%
Net margin
10.1%
Return on equity
-4.3%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$1.09B$1.14B$1.13B$1.13B$1.09B$943.37M$963.01M$975.78M$1.04B$882.06M
Cost of Revenue$493.13M$503.30M$500.91M$502.43M$466.17M$395.89M$410.79M$420.20M$464.67M$381.77M
Gross Profit$595.58M$634.46M$624.45M$625.29M$620.65M$547.47M$552.22M$555.58M$576.50M$500.29M
Operating Income$309.41M$336.77M$342.43M-$22.41M$329.92M$297.40M$291.15M$67.50M$215.47M$205.64M
Net Income$190.30M$214.60M$209.34M-$82.31M$205.38M$164.68M$142.28M-$35.80M$339.57M$69.39M
EPS (Diluted)$3.91$4.29$4.17$-1.65$4.04$3.25$2.78$-0.69$6.34$1.30
Total Assets$3.49B$3.40B$3.32B$3.35B$3.67B$3.43B$3.51B$3.44B$3.76B$3.91B
Total Liabilities$1.61B$1.57B$1.66B$1.91B$2.09B$2.07B$2.34B$2.35B$2.58B$3.09B
Shareholders' Equity$1.89B$1.83B$1.66B$1.45B$1.58B$1.36B$1.17B$1.10B$1.18B$822.55M
Cash & Equivalents$63.87M$97.88M$46.47M$58.49M$27.18M$32.30M$94.76M$27.53M$32.55M$41.85M
Operating Cash Flow$257.63M$251.51M$248.93M$229.72M$259.92M$235.61M$217.12M$189.28M$210.11M$148.67M
Capital Expenditures$11.18M$8.22M$9.55M$7.78M$9.64M$22.24M$14.56M$10.48M$12.53M$2.98M
Shares Outstanding48.72M50.08M50.18M49.89M50.84M50.60M51.14M52.07M53.53M53.36M